Corsair Capital Management, L.P. Renovo Rx, Inc. Transaction History
Corsair Capital Management, L.P.
- $467 Million
- Q2 2025
A detailed history of Corsair Capital Management, L.P. transactions in Renovo Rx, Inc. stock. As of the latest transaction made, Corsair Capital Management, L.P. holds 95,373 shares of RNXT stock, worth $120,169. This represents 0.03% of its overall portfolio holdings.
Number of Shares
95,373
Previous 187,700
49.19%
Holding current value
$120,169
Previous $185,000
32.43%
% of portfolio
0.03%
Previous 0.05%
Shares
2 transactions
Others Institutions Holding RNXT
# of Institutions
28Shares Held
9.77MCall Options Held
0Put Options Held
0-
Aigh Capital Management LLC Baltimore, MD3.47MShares$4.37 Million2.59% of portfolio
-
Awm Investment Company, Inc. New York, NY1.87MShares$2.36 Million0.35% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.66MShares$2.1 Million0.0% of portfolio
-
Bank Of The West975KShares$1.23 Million0.27% of portfolio
-
Bleichroeder LP New York, NY500KShares$630,0000.21% of portfolio
About RenovoRx, Inc.
- Ticker RNXT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 9,066,860
- Market Cap $11.4M
- Description
- RenovoRx, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for the treatment of solid tumors. Its lead product candidate is RenovoGem, a drug and device combination consisting of intra-arterial gemcitabine and RenovoCath that is in Phase III clinical trials for the locally advanced pancreatic cancer. RenovoRx, In...